Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” second quarter 2025 ...

Becton, Dickinson and Company (NYSE:BDX) is one of the stocks on Jim Cramer’s radar. Cramer mentioned the stock in light of ...

Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 ...

In its second quarter 2025 investor letter, Oakmark Global Fund highlighted stocks such as Becton, Becton, Dickinson and ...

Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A ...

Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...

See the latest Becton Dickinson & Co stock price (BDX:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

Becton Dickinson & Co. closed 29.02% below its 52-week high of $251.99, which the company reached on February 3rd.

Becton Dickinson BDX shares ended the last trading session 5.7% higher at $279.97. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

NYSE:BDX Debt to Equity History January 11th 2025 A Look At Becton Dickinson's Liabilities. Zooming in on the latest balance sheet data, we can see that Becton Dickinson had liabilities of US$8 ...

Becton, Dickinson, and Company (BDX), based in Franklin Lakes, New Jersey, is a leading global medical technology firm dedicated to advancing healthcare through innovative medical devices ...